References
- 1GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. LANCET. 2020; 396: 1204–22. DOI: 10.1016/S0140-6736(20)30925-9
- 2Zhao D. Epidemiological Features of Cardiovascular Disease in Asia. JACC: Asia. 2021; 1: 1–13. DOI: 10.1016/j.jacasi.2021.04.007
- 3The Writing Committee of the Report on Cardiovascular Health and Diseases in China. Interpretation of Report on Cardiovascular Health and Diseases in China 2020. CHIN J CARDIOVASC MED. 2021; 26: 209–218. DOI: 10.3969/j.issn.1007-5410.2021.03.001
- 4GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. LANCET NEUROL. 2021; 20: 795–820. DOI: 10.1016/S1474-4422(21)00252-0
- 5Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): A prospective cohort study. LANCET. 2020; 395: 785–94. DOI: 10.1016/S0140-6736(19)32007-0
- 6Su JT, Zhang YM, Wang P, Du J, Wei ZH. Comparative analysis of comprehensive health status among 31 provinces in China and 134 countries (regions) in 2015. ZHŌNGHUÁ YÙFÁNG-YĪXUÉ ZÁZHÌ. 2020; 54: 165–8. DOI: 10.3760/cma.j.issn.0253-9624.2020.02.010.
- 7Chilunga FP, Henneman P, Requena Méndez A, et al. Hyperuricaemia and its association with 10-year risk of cardiovascular disease among migrant and non-migrant African populations: the RODAM study. TROP MED INT HEALTH. 2020; 25: 496–505. DOI: 10.1111/tmi.13362
- 8Chaudhary NS, Bridges SL, Saag KG, et al. Severity of Hypertension Mediates the Association of Hyperuricemia With Stroke in the REGARDS Case Cohort Study. HYPERTENSION. 2020; 75: 246–56. DOI: 10.1161/HYPERTENSIONAHA.119.13580
- 9Sun Y, Zhang H, Tian W, et al. Association between serum uric acid levels and coronary artery disease in different age and gender: A cross-sectional study. AGING CLIN EXP RES. 2019; 31: 1783–90. DOI: 10.1007/s40520-019-01137-2
- 10Tu W, Wu J, Jian G, et al. Asymptomatic hyperuricemia and incident stroke in elderly Chinese patients without comorbidities. EUR J CLIN NUTR. 2019; 73: 1392–402. DOI: 10.1038/s41430-019-0405-1
- 11Lai X, Yang L, Légaré S, et al. Dose-response relationship between serum uric acid levels and risk of incident coronary heart disease in the Dongfeng-Tongji Cohort. INT J CARDIOL. 2016; 224: 299–304. DOI: 10.1016/j.ijcard.2016.09.035
- 12Navaneethan SD, Beddhu S. Associations of serum uric acid with cardiovascular events and mortality in moderate chronic kidney disease. NEPHROL DIAL TRANSPL. 2008; 24: 1260–6. DOI: 10.1093/ndt/gfn621
- 13Chuang S, Chen J, Yeh W, Wu C, Pan W. Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort. INT J CARDIOL. 2012; 154: 316–21. DOI: 10.1016/j.ijcard.2011.06.055
- 14Chien K, Hsu H, Sung F, Su T, Chen M, Lee Y. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. ATHEROSCLEROSIS. 2005; 183: 147–55. DOI: 10.1016/j.atherosclerosis.2005.01.018
- 15Wang H, Jacobs DR, Gaffo AL, Gross MD, Goff DC, Carr JJ. Serum Urate and Incident Cardiovascular Disease: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. PLOS ONE. 2015; 10:
e138067 . DOI: 10.1371/journal.pone.0138067 - 16Wu J, Lei G, Wang X, et al. Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities. ONCOTARGET. 2017; 8: 80688–99. DOI: 10.18632/oncotarget.21079
- 17Musacchio E, Perissinotto E, Sartori L, et al. Hyperuricemia, Cardiovascular Profile, and Comorbidity in Older Men and Women: The Pro.V.A. Study. REJUV RES. 2017; 20: 42–9. DOI: 10.1089/rej.2016.1834
- 18Yang Y, Tian J, Zeng C, et al. Relationship between hyperuricemia and risk of coronary heart disease in a middle-aged and elderly Chinese population. J INT MED RES. 2017; 45: 254–60. DOI: 10.1177/0300060516673923
- 19Zhao X, Hong F, Yin J, et al. Cohort profile: the China Multi-Ethnic cohort (CMEC) study. INT J EPIDEMIOL. 2020; 50: 721–721l. DOI: 10.1093/ije/dyaa185
- 20Xu H, Guo B, Qian W, et al. Dietary Pattern and Long-Term Effects of Particulate Matter on Blood Pressure: A Large Cross-Sectional Study in Chinese Adults. HYPERTENSION. 2021; 78: 184–94. DOI: 10.1161/HYPERTENSIONAHA.121.17205
- 21Zhang N, Xiao X, Xu J, et al. Dietary Approaches to Stop Hypertension (DASH) diet, Mediterranean diet and blood lipid profiles in less-developed ethnic minority regions. BRIT J NUTR. 2021; 1–25. DOI: 10.1017/S0007114521004013
- 22Wang Y, Zeng Y, Zhang X, et al. Daytime Napping Duration Is Positively Associated With Risk of Hyperuricemia in a Chinese Population. J CLIN ENDOCR METAB. 2021; 106: e2096–105. DOI: 10.1210/clinem/dgab043
- 23Wang L, Chen G, Pan Y, et al. Association of long-term exposure to ambient air pollutants with blood lipids in Chinese adults: The China Multi-Ethnic Cohort study. ENVIRON RES. 2021; 197: 111174. DOI: 10.1016/j.envres.2021.111174
- 24Li D, Yin W, Yi Y, et al. Development and validation of a more accurate estimating equation for glomerular filtration rate in a Chinese population. KIDNEY INT. 2019; 95: 636–46. DOI: 10.1016/j.kint.2018.10.019
- 25Liu X, Bragg F, Yang L, et al. Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women: A 9-year prospective study of 0.5 million people. LANCET PUBLIC HEALTH. 2018; 3: e167–76. DOI: 10.1016/S2468-2667(18)30026-4
- 26Millwood IY, Li L, Smith M, et al. Alcohol consumption in 0.5 million people from 10 diverse regions of China: prevalence, patterns and socio-demographic and health-related correlates. INT J EPIDEMIOL. 2017; 46: 2103. DOI: 10.1093/ije/dyx210
- 27Du H, Bennett D, Li L, et al. Physical activity and sedentary leisure time and their associations with BMI, waist circumference, and percentage body fat in 0.5 million adults: The China Kadoorie Biobank study. AM J CLIN NUTR. 2013; 97: 487–96. DOI: 10.3945/ajcn.112.046854
- 28Chinese Society of Endocrinology. Chinese Guideline of Hyperuricemia and Gout. CHIN J ENDOCRINOL METAB. 2013; 29: 913–20. DOI: 10.3760/cma.j.issn.1673-4157.2013.06.005
- 29Yang B, Guo Y, Morawska L, et al. Ambient PM1 air pollution and cardiovascular disease prevalence: Insights from the 33 Communities Chinese Health Study. ENVIRON INT. 2019; 123: 310–7. DOI: 10.1016/j.envint.2018.12.012
- 30Davies NM, Dickson M, Davey SG, van den Berg GJ, Windmeijer F. The Causal Effects of Education on Health Outcomes in the UK Biobank. NAT HUM BEHAV. 2018; 2: 117–25. DOI: 10.1038/s41562-017-0279-y
- 31Qin XD, Qian Z, Vaughn MG, et al. Gender-specific differences of interaction between obesity and air pollution on stroke and cardiovascular diseases in Chinese adults from a high pollution range area: A large population based cross sectional study. SCI TOTAL ENVIRON. 2015; 529: 243–8. DOI: 10.1016/j.scitotenv.2015.05.041
- 32National Bureau of Statistics of China. 2010 Population Census. Retrieved from:
http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.htm . (Accessed 1 June 2021). - 33Sharaf El Din UAA, Salem MM, Abdulazim DO. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. J ADV RES. 2017; 8: 537–48. DOI: 10.1097/HJH.0b013e3282f240bf
- 34Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. KIDNEY INT. 2005; 67: 1739–42. DOI: 10.1111/j.1523-1755.2005.00273.x
- 35Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J HYPERTENS. 2008; 26: 269–75. DOI: 10.1097/HJH.0b013e3282f240bf
- 36Ruggiero C, Cherubini A, Ble A, et al. Uric acid and inflammatory markers. EUR HEART J. 2006; 27: 1174–81. DOI: 10.1093/eurheartj/ehi879
- 37Park JH, Song JS, Choi ST. Increased Carotid Intima-Media Thickness (IMT) in Hyperuricemic Individuals May Be Explained by Hyperhomocysteinemia Associated with Renal Dysfunction: A Cross-Sectional Study. J KOREAN MED SCI. 2019; 34:
e237 . DOI: 10.3346/jkms.2019.34.e237 - 38Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. LANCET. 2021; 397: 2385–438. DOI: 10.1016/S0140-6736(21)00684-X
